The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksESC.L Regulatory News (ESC)

  • There is currently no data for ESC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Schedule One Update - Dorcaster Plc

18 Apr 2017 16:30

RNS Number : 6357C
AIM
18 April 2017
 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

 

Dorcaster plc (the "Company") (to be renamed as Escape Hunt plc on Admission)

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

 

c/o Atticus Legal LLP

Castlefield House

Liverpool Road

Manchester

M3 4SB

 

COUNTRY OF INCORPORATION:

 

England and Wales

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

 

Before Admission: www.dorcasterplc.com/documents/

After Admission: www.investors.escapehunt.com

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

 

Admission is being sought as a result of a reverse take-over under Rule 14.

 

The Company was admitted to AIM on 8 July 2016. The Company's investment policy is to acquire controlling stakes in one or more quoted or unquoted businesses or companies (in whole or in part) in the consumer and leisure sectors.

 

The Escape Hunt Group is a global provider of live 'escape the room' experiences, with a franchised global network (including one owner-operated branch) of 38 branches operating 214 rooms across 20 countries.

 

Going forward, the Directors and the Proposed Directors intend to focus on rolling out owner-operated branches, initially in the UK and another European jurisdiction, whilst also continuing to franchise and sub-franchise.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

 

Number of ordinary shares of 1.25 pence each ("Ordinary Shares") to be admitted to trading: 10,370,370

 

There are no restrictions as to transferability of the Ordinary Shares.

 

No Ordinary Shares will be held in treasury on Admission.

 

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

 

Capital to be raised on Admission: £14m

Anticipated market capitalisation at Admission: £27m

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

 

Current: 69.8%

Post Admission: 51.8%

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:

 

None

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

 

Directors

Richard Sidney Rose, Non-executive Chairman

Hubert Gerard Patrick van den Bergh, Non-executive Director (to step down at Admission)

 

Proposed Directors

Richard John Harpham, Chief Executive Officer

Alistair Kynoch Rae, Chief Financial Officer

Adrian Paul Jones, Non-executive Director

Karen Bach, Non-executive Director

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

 

Before Admission

SHAREHOLDER

NUMBER OF ORDINARY SHARES

ORDINARY SHARES AS % OF SHARE CAPITAL

Hargreave Hale Limited

2,250,000

22.5%

Arrowgrass Capital Partners LLP

2,250,000

22.5%

Hubert Gerard Patrick Van Den Bergh

1,682,884

16.8%

Karen Elisabeth Dind Jones

697,721

7.0%

Peel Hunt LLP

648,986

6.5%

Dominic Rose

592,593

5.9%

Jessica Rose

592,593

5.9%

Jaime Sarah Rose Scudamore

592,593

5.9%

 

 

After Admission

SHAREHOLDER

NUMBER OF ORDINARY SHARES

ORDINARY SHARES AS % OF SHARE CAPITAL

Arrowgrass Capital Partners LLP

3,250,000

16.0%

Hargreave Hale Limited

3,164,000

15.6%

Paul Bartosik

1,777,778

8.8%

Adrian Jones

1,777,777

8.8%

Killik & Co LLP

1,700,000

8.4%

Legal & General Investment Management Ltd

1,355,000

6.7%

J O Hambro Capital Management Limited

1,355,000

6.7%

Octopus Investments Limited

1,220,000

6.0%

Unicorn Asset Management Limited

914,000

4.5%

Gresham House Asset Management Limited

747,390

3.7%

Peel Hunt LLP

648,986

3.2%

Amati Global Investors Limited

610,000

3.0%

 

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

None other than disclosed in the Admission Document

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

 

(i) 31 Dec

(ii) 31 Dec 2016

(iii) 30 Sept 2017, 30 June 18, 30 Sept 18

 

 

EXPECTED ADMISSION DATE:

 

3 May 2017

 

NAME AND ADDRESS OF NOMINATED ADVISER:

 

Peel Hunt LLPMoor House120 London WallLondonEC2Y 5ET

 

NAME AND ADDRESS OF BROKER:

 

Peel Hunt LLPMoor House120 London WallLondonEC2Y 5ET

 

Stockdale Securities Limited

Beaufort House

15 St Botolph Street

London

EC3A 7BB

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

A copy of the Admission Document containing full details about the applicant and the admission of its securities will be available on the Company's website at: 

 

www.dorcasterplc.com/documents/

 

DATE OF NOTIFICATION:

 

18 April 2017

 

NEW/ UPDATE:

 

Update

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIMGGUBGCUPMGAR
Date   Source Headline
15th May 20202:06 pmRNSSecond Price Monitoring Extn
15th May 20202:00 pmRNSPrice Monitoring Extension
12th May 20207:00 amRNSAppointment of Joint Broker
12th May 20207:00 amRNS2019 Full Year Results
28th Apr 202010:42 amRNSHolding(s) in Company
16th Apr 20207:00 amRNSCOVID-19 Update
26th Mar 202010:06 amRNSHolding(s) in Company
26th Mar 202010:00 amRNSHolding(s) in Company
19th Mar 20207:00 amRNSTrading Update and Impact of COVID 19
18th Mar 20204:49 pmRNSHolding(s) in Company
17th Mar 20204:08 pmRNSHolding(s) in Company
3rd Mar 20207:00 amRNSBBC Studios and ESC launch new Doctor Who game
26th Feb 20202:13 pmRNSHolding(s) in Company
24th Feb 20201:24 pmRNSHolding(s) in Company Replacement
24th Feb 202010:44 amRNSHolding(s) in Company
24th Feb 202010:36 amRNSHolding(s) in Company
10th Feb 20207:00 amRNSHolding(s) in Company
10th Feb 20207:00 amRNSPresenting at The Growth & Innovation Forum
4th Feb 20207:00 amRNSTrading Statement
16th Dec 20197:00 amRNSDirectorate Change
20th Nov 201910:10 amRNSHolding(s) in Company
27th Sep 20197:00 amRNSUnaudited Half Yearly Results
23rd Sep 20197:00 amRNSUS and Canada Franchise Deal Signed
31st Jul 20197:00 amRNSBoard Change
27th Jun 20191:53 pmRNSResult of AGM
25th Jun 201912:27 pmRNSChange of Adviser
21st Jun 20192:44 pmRNSDirectors' Disclosure
18th Jun 20197:00 amRNSNotice of AGM
6th Jun 20193:44 pmRNSHolding(s) in Company
6th Jun 20198:07 amRNSHolding(s) in Company
6th Jun 20198:05 amRNSHolding(s) in Company
4th Jun 20194:02 pmRNSHolding(s) in Company
4th Jun 201910:37 amRNSHolding(s) in Company
31st May 201911:40 amRNSResult of Meeting and Total Voting Rights
13th May 20192:46 pmRNSResult of Placing and Posting of Circular
13th May 20197:01 amRNSConditional Placing to raise a minimum of £4.0M
13th May 20197:00 amRNS2018 Full Year Results
29th Apr 20197:00 amRNSHeads of terms for US and Canada franchise deal
3rd Apr 20194:01 pmRNSHolding(s) in Company
23rd Jan 20197:00 amRNSPre-close trading statement
18th Sep 20187:00 amRNSInterim Results
4th Sep 20184:44 pmRNSHolding(s) in Company
3rd Sep 20187:00 amRNSHolding(s) in Company
13th Aug 20181:57 pmRNSHolding(s) in Company
23rd Jul 20187:01 amRNSTrading Update
23rd Jul 20187:00 amRNSLicence agreement with BBC Studios Doctor Who
26th Jun 20183:24 pmRNSHolding(s) in Company
26th Jun 20188:16 amRNSHolding(s) in Company
8th Jun 20184:21 pmRNSHolding(s) in Company
30th May 20185:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.